TrialJournal of neuromuscular diseases2023

Efficacy and Safety of Viltolarsen in Boys With Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study.

Paula R Clemens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.